trending Market Intelligence /marketintelligence/en/news-insights/trending/j2jd-khatdcwqvbsckux4a2 content esgSubNav
In This List

Cancer therapy developer Athenex appoints director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Cancer therapy developer Athenex appoints director

Buffalo, N.Y.-based biopharmaceutical company Athenex Inc. appointed Benson Tsang as a board member.

The cancer therapy developer said the appointment is effective July 1, the same day James Zukin steps down from the board.

Tsang, who has over three decades of financial and general management experience, is the former CFO of WuXi Pharmatech Inc.

Tsang currently provides financial and operational advisory services through his consultancy firm to clients in the USA, Canada and China, Athenex said in a statement.